BCAX - Bicara Therapeutics Inc. Common Stock
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$28.60
DETAILS
HIGH:
$42.00
LOW:
$18.00
MEDIAN:
$28.00
CONSENSUS:
$28.60
UPSIDE:
31.92%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-18 | Mazumdar Claire | director, officer: Chief Executive Officer | SELL | 2,978 | $20.35 | $61K |
| 2026-05-18 | Mazumdar Claire | director, officer: Chief Executive Officer | M-Exempt | 15,000 | $3.79 | $57K |
| 2026-05-18 | Mazumdar Claire | director, officer: Chief Executive Officer | SELL | 12,022 | $19.96 | $240K |
| 2026-05-15 | Cohlhepp Ryan | director, officer: President and COO | M-Exempt | 8,000 | $3.79 | $30K |
| 2026-05-15 | Cohlhepp Ryan | director, officer: President and COO | SELL | 8,000 | $20.29 | $162K |
| 2026-05-15 | Cohlhepp Ryan | director, officer: President and COO | SELL | 4,500 | $20.29 | $91K |
| 2026-05-08 | Schelman William | officer: Chief Medical Officer | A-Award | 85,000 | $22.58 | $1.9M |
| 2026-05-08 | Schelman William | officer: Chief Medical Officer | ? | 150,000 | $16.61 | $2.5M |
| 2026-05-08 | Schelman William | officer: Chief Medical Officer | ? | 25,000 | $16.76 | $419K |
| 2026-04-27 | Raben David | officer: Chief Medical Officer | M-Exempt | 5,500 | $3.79 | $21K |
| 2026-04-27 | Raben David | officer: Chief Medical Officer | SELL | 5,500 | $22.88 | $126K |
| 2026-04-21 | Hyep Ivan | officer: Chief Financial Officer | SELL | 9,200 | $23.00 | $212K |
| 2026-04-21 | Hyep Ivan | officer: Chief Financial Officer | M-Exempt | 9,200 | $3.79 | $35K |
| 2026-04-16 | Mazumdar Claire | director, officer: Chief Executive Officer | M-Exempt | 7,080 | $5.45 | $39K |
| 2026-04-16 | Mazumdar Claire | director, officer: Chief Executive Officer | M-Exempt | 7,454 | $3.79 | $28K |
| 2026-04-16 | Mazumdar Claire | director, officer: Chief Executive Officer | M-Exempt | 8,226 | $4.44 | $36K |
| 2026-04-20 | Mazumdar Claire | director, officer: Chief Executive Officer | SELL | 15,000 | $23.61 | $354K |
| 2026-04-20 | Mazumdar Claire | director, officer: Chief Executive Officer | M-Exempt | 15,000 | $3.79 | $57K |
| 2026-04-15 | Cohlhepp Ryan | director, officer: President and COO | SELL | 8,000 | $23.01 | $184K |
| 2026-04-15 | Cohlhepp Ryan | director, officer: President and COO | SELL | 4,500 | $23.01 | $104K |
| 2026-04-15 | Cohlhepp Ryan | director, officer: President and COO | M-Exempt | 8,000 | $3.79 | $30K |
| 2026-03-25 | Raben David | officer: Chief Medical Officer | SELL | 5,500 | $18.95 | $104K |
| 2026-03-25 | Raben David | officer: Chief Medical Officer | M-Exempt | 5,500 | $3.79 | $21K |
| 2026-03-23 | Hyep Ivan | officer: Chief Financial Officer | M-Exempt | 9,200 | $3.79 | $35K |
| 2026-03-23 | Hyep Ivan | officer: Chief Financial Officer | SELL | 9,200 | $18.52 | $170K |